Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

A Retrospective Analysis Of The Association Between Common Myeloablative Conditioning Regimens and Hepatotoxicity

Rushang D. Patel, MD, PhD, Thomas R. Klumpp, MD, Mary Ellen Martin, MD, Patricia Kropf, MD, Omotayo O. Fasan, MBBS, Kenneth F. Mangan, MD

Blood (2013) 122 (21): 5515.

https://doi.org/10.1182/blood.V122.21.5515.5515

Published: 2013

Journal Articles

Confirmation of A Strong Relationship Between Race and Probability of Transplant Among Patients Referred for Hematopoietic Cell Transplantation (HCT) for Hematological Maliganancies – A 17 Year Experience

Manish Sharma, MD, Thomas R Klumpp, MD, John A Ulicny, MS, Omotayo O. Fasan, MBBS, Patricia Kropf, MD, Mary Ellen Martin, MD, Kenneth F. Mangan, MD

Blood (2012) 120 (21): 4266.

https://doi.org/10.1182/blood.V120.21.4266.4266

Published: 2012

Journal Articles

Evaluating Trends in Diagnostic and Prognostic Testing for Multiple Myeloma

C. J. Fidler, Ahmed Kamel Abou Hussein, MD, Neel Gandhi, Vinit Karur, MD, Manish Sharma, MD, Thomas R Klumpp, MD, Patricia Kropf, MD, Mary Ellen Martin, MD, Robert V. Emmons, MD, Kenneth F. Mangan, MD

Blood (2011) 118 (21): 2067.

https://doi.org/10.1182/blood.V118.21.2067.2067

Published: 2011

Journal Articles

LACK of ASSOCIATION BETWEEN Race and Probability of TRANSPLANT AMONG PATIENTS Referred for Hematopoietic CELL TRANSPLANTATION (HCT) for MULTIPLE Myeloma

Manish Sharma, MD, Michael Bromberg, MD, PhD, Thomas R. Klumpp, MD, Patricia Kropf, MD, Mary Ellen Martin, MD, Robert V. Emmons, MD, Kenneth F. Mangan, MD

Blood (2011) 118 (21): 3129.

https://doi.org/10.1182/blood.V118.21.3129.3129

Published: 2011

Journal Articles

High-Dose Cytoxan, Etoposide, and Cisplatin Followed by Autologous Hematopoietic Cell Transplantation for the Treatment of Hodgkin Lymphoma: A 20-Year Single-Institutional Experience.

Thomas R. Klumpp, MD, Moshe C. Chasky, MD, Robert V. Emmons, MD, Mary E. Martin, MD, James L. Gajewski, MD, Kenneth F. Mangan, MD

Blood (2007) 110 (11): 1913.

https://doi.org/10.1182/blood.V110.11.1913.1913

Published: 2007

Journal Articles

A Randomized Phase 3 Study of Peripheral Blood Progenitor Cell Mobilization With Stem Cell Factor and Filgrastim in High-Risk Breast Cancer Patients

Elizabeth J. Shpall, Catherine A. Wheeler, Stewart A. Turner, Saul Yanovich, Randy A. Brown, Andrew L. Pecora, Thomas C. Shea, Kenneth F. Mangan, Stephanie F. Williams, C. Fred LeMaistre, Gwynn D. Long, Roy Jones, Mark W. Davis, Robyn Murphy-Filkins, William R.L. Parker, John A. Glaspy

Blood (1999) 93 (8): 2491–2501.

https://doi.org/10.1182/blood.V93.8.2491

Published: 1999

NARROW

A Retrospective Analysis Of The Association Between Common Myeloablative Conditioning Regimens and Hepatotoxicity

Confirmation of A Strong Relationship Between Race and Probability of Transplant Among Patients Referred for Hematopoietic Cell Transplantation (HCT) for Hematological Maliganancies – A 17 Year Experience

Evaluating Trends in Diagnostic and Prognostic Testing for Multiple Myeloma

LACK of ASSOCIATION BETWEEN Race and Probability of TRANSPLANT AMONG PATIENTS Referred for Hematopoietic CELL TRANSPLANTATION (HCT) for MULTIPLE Myeloma

High-Dose Cytoxan, Etoposide, and Cisplatin Followed by Autologous Hematopoietic Cell Transplantation for the Treatment of Hodgkin Lymphoma: A 20-Year Single-Institutional Experience.

A Randomized Phase 3 Study of Peripheral Blood Progenitor Cell Mobilization With Stem Cell Factor and Filgrastim in High-Risk Breast Cancer Patients

Email alerts

ASH Publications

American Society of Hematology

A Retrospective Analysis Of The Association Between Common Myeloablative Conditioning Regimens and Hepatotoxicity

Confirmation of A Strong Relationship Between Race and Probability of Transplant Among Patients Referred for Hematopoietic Cell Transplantation (HCT) for Hematological Maliganancies – A 17 Year Experience

Evaluating Trends in Diagnostic and Prognostic Testing for Multiple Myeloma

LACK of ASSOCIATION BETWEEN Race and Probability of TRANSPLANT AMONG PATIENTS Referred for Hematopoietic CELL TRANSPLANTATION (HCT) for MULTIPLE Myeloma

High-Dose Cytoxan, Etoposide, and Cisplatin Followed by Autologous Hematopoietic Cell Transplantation for the Treatment of Hodgkin Lymphoma: A 20-Year Single-Institutional Experience.

A Randomized Phase 3 Study of Peripheral Blood Progenitor Cell Mobilization With Stem Cell Factor and Filgrastim in High-Risk Breast Cancer Patients

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only